- Characterization of acquired paclitaxel resistance of breast cancer cells and involvement of ABC transporters2016 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University
- Novel Stony Brook taxanes are efficacious in paclitaxel-resistant ovarian cancer models both in vitro and in vivoPublication without faculty affiliation
- Anticancer regimens containing third generation taxanes SB-T-121605 and SB-T-121606 are highly effective in resistant ovarian carcinoma model2022 | Third Faculty of Medicine, First Faculty of Medicine, Central Library of Charles University, Faculty of Medicine in Pilsen
- Differentially Expressed Mitochondrial Proteins in Human MCF7 Breast Cancer Cells Resistant to Paclitaxel2019 | Third Faculty of Medicine
- Cell death induced by novel fluorinated taxanes in drug-sensitive and drug-resistant cancer cells2011 | Publication without faculty affiliation
- Substituents at the C3 ' and C3 ' N positions are critical for taxanes to overcome acquired resistance of cancer cells to paclitaxel2018 | Third Faculty of Medicine
- Ketone-selenoesters as potential anticancer and multidrug resistance modulation agents in 2D and 3D ovarian and breast cancer in vitro models2022 | Faculty of Medicine in Pilsen
- The role of trip6, abcc3 and cps1 expression in resistance of ovarian cancer to taxanes2022 | Third Faculty of Medicine, First Faculty of Medicine, Faculty of Medicine in Pilsen, Second Faculty of Medicine
- Transport, metabolism, cytotoxicity and effects of novel taxanes on the cell cycle in MDA-MB-435 and NCI/ADR-RES cells2012 | Third Faculty of Medicine